30th Apr 2019 07:00
Mereo BioPharma Group plc
("Mereo" or the "Company")
Notification of Director Dealing
London, April 30, 2019 - Mereo BioPharma Group plc (AIM: MPH), a clinical stage UK based biopharmaceutical company focused on rare diseases, received notification that on 29 April 2019, Peter Fellner, Chairman of Mereo BioPharma, purchased 30,000 new ordinary shares in the Company at a price of GBP1.28 per share, as set out in the table below.
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Peter Fellner | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chairman | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF GBP0.003 EACH
| ||||
b) | Nature of the transaction | PURCHASE OF ORDINARY SHARES | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information: volume, Price | Aggregated volume: 30,000 ordinary shares Aggregated price: GBP1.28 | ||||
e) | Date of the transaction | 2019-04-29 | ||||
f) | Place of the transaction | AIMX | ||||
Related Shares:
MPH.L